Glaxo Says FDA Call About Zofran Suits Not 'Covert Lobbying'
GlaxoSmithKline attorneys have told a Massachusetts federal judge that a 30-minute phone call with the U.S. Food and Drug Administration about multidistrict litigation alleging its anti-nausea medication Zofran causes birth defects...To view the full article, register now.
Already a subscriber? Click here to view full article